The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
The Cholinergic Hypothesis of Geriatric Memory Dysfunction
Abstract
Biochemical, electrophysiological, and pharmacological evidence supporting a role for cholinergic dysfunction in age-related memory disturbances is critically reviewed. An attempt has been made to identify pseudoissues, resolve certain controversies, and clarify misconceptions that have occurred in the literature. Significant cholinergic dysfunctions occur in the aged and demented central nervous system, relationships between these changes and loss of memory exist, similar memory deficits can be artificially induced by blocking cholinergic mechanisms in young subjects, and under certain tightly controlled conditions reliable memory improvements in aged subjects can be achieved after cholinergic stimulation. Conventional attempts to reduce memory impairments in clinical trials hav not been therapeutically successful, however. Possible explanations for these disappointments are given and directions for future laboratory and clinical studies are suggested.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“During the course of AD pathogenesis, cholinergic neurons in the nucleus basalis of Meynert and other septal nuclei that project widely throughout the cortex are lost, causing a general cholinergic deficit (Bartus et al., 1982).”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Bartus et al., 1982
Citations
Cites
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Perry, E., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P., & Perry, R. H. (1978) · British medical journal · doi:10.1136/bmj.2.6150.1457 · Cited by 2,043
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981) · Annals of Neurology · doi:10.1002/ana.410100203 · Cited by 1,736
Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500
Human Memory and the Cholinergic System
Drachman, D. A. (1974) · Archives of Neurology · doi:10.1001/archneur.1974.00490320001001 · Cited by 1,398
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
Bowen, D. M., Smith, C. B., White, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,313
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,293
THE ASCENDING CHOLINERGIC RETICULAR SYSTEM: NEOCORTICAL, OLFACTORY AND SUBCORTICAL PROJECTIONS
Shute, C. C. D., & Lewis, P. R. (1967) · Brain · doi:10.1093/brain/90.3.497 · Cited by 1,120
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. E. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,070
Research works printed but not linked: 36
- BARBEAU, A, LECITHIN IN NEUROLOGIC DISORDERS, NEW ENGLAND JOURNAL OF MEDICINE 299: 200 (1978).
- BARTUS, R.T., AGING 10: 85 (1979).
- BONDAREFF, W, LANCET 1: 784 (1981).
- BOWEN, D.M., TREATMENT OF ALZHEIMERS-DISEASE - A CAUTIONARY NOTE, NEW ENGLAND JOURNAL OF MEDICINE 305: 1016 (1981).
- BOYD, W.D., CLINICAL EFFECTS OF CHOLINE IN ALZHEIMER SENILE DEMENTIA, LANCET 2: 711 (1977).
- CAIRD, W.K., J GERONTOL 21: 195 (1966).
- DAVIES, P, BRAIN RES 138: 385 (1978).
- DAVIS, K.L., LIFE SCI 22: 2699 (1978).
- DAVIS, K.L., CHOLINE FOR TARDIVE-DYSKINESIA, NEW ENGLAND JOURNAL OF MEDICINE 293: 152 (1975).
- DAVIS, K.L., ENHANCEMENT OF MEMORY BY PHYSOSTIGMINE, NEW ENGLAND JOURNAL OF MEDICINE 301: 946 (1979).
- ECKERNAS, S. A., ACTA PHYSIOLOGICA SCANDINAVICA 449: 1 (1977).
- ETIENNE, P, LANCET 1: 500 (1978).
- ETIENNE, P, LECITHIN IN ALZHEIMERS-DISEASE, LANCET 2: 1206 (1978).
- FERRIS, S. H., Combination Choline/Piracetam Treatment of Senile Dementia, PSYCHOPHARMACOLOGY BULLETIN 18: 94 (1982).
- FORNO, L. S., JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 37: 614 (1978).
- FROLKIS, V.V., INTERDISCIP TOP GERO 16: 1 (1979).
- GIBSON, G.E., NEUROTRANSMITTER AND CARBOHYDRATE-METABOLISM DURING AGING AND MILD HYPOXIA, NEUROBIOLOGY OF AGING 2: 165 (1981). · DOI
- GLURGEA, C, CURR DEV PSYCHOPHARM 3: 221 (1976).
- HOLBERT, N.M., GERONTOLOGY 1: 131 (1976).
- JENSEN, R.A., AGING 1980S PSYCHOL: 191 (1980).
- KATZMAN, R, LANCET 2: 1403 (1976).
- KUHAR, J.J., BIOL CHOLINERGIC FUN: 3 (1976).
- KUTZ, P, BEHAV REV 1: 25 (1977).
- LIPPA, A.S., NEUROBIOL AGING 1: 10 (1980).
- MARRIOTT, J.G., SOCIETY FOR NEUROSCIENCE. ABSTRACTS 5: 319 (1979).
- MORIN, A.M., NEUROCHEM RES 5: 310 (1980).
- PALACIOS, J.M., MOL PHARM 16: 1984 (1979).
- PERRY, E.K., NORADRENERGIC AND CHOLINERGIC SYSTEMS IN SENILE DEMENTIA OF ALZHEIMER TYPE, LANCET 2: 149 (1981).
- RENVOISE, D.G., NEW ENGLAND JOURNAL OF MEDICINE 301: 330 (1979).
- SCHMIDT, D.E., NEUROSCIENCE ABSTRACTS 4: 433 (1978).
- SIGNORET, J.L., INFLUENCE OF CHOLINE ON AMNESIA IN EARLY ALZHEIMERS-DISEASE, LANCET 2: 837 (1978).
- SMITH, C.M., CHOLINE THERAPY IN ALZHEIMERS-DISEASE, LANCET 2: 318 (1978).
- SMITH, C.M., LANCET 1: 42 (1979).
- VROULIS, G.A., PSYCHOPHARMACOLOGY BULLETIN 17: 127 (1981).
- WHITELEY, A, REV NEUROL 135: 565 (1973).
- YATES, C.M., DOPAMINE IN ALZHEIMERS-DISEASE AND SENILE DEMENTIA, LANCET 2: 851 (1979).
Cited by
Sorted by citations
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Metadata
- Authors
- Bartus, R. T., Dean, R. L., Beer, B., & Lippa, A. S.
- Affiliations
- NYU Langone Health (US)
- Department of CNS Research, Lederle Laboratories of American Cyanamid Co., Pearl River, New York 10965.
- Venue
- Science
- Published
- 1982-07-30
- Volume
- 217
- Issue
- 4558
- Pages
- 408-414
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1994067502
- Cited by
- 5,545
- References
- 158
- Citations by year
- 2026: 66 · 2025: 98 · 2024: 90 · 2023: 107 · 2022: 130 · 2021: 142 · 2020: 123 · 2019: 119 · 2018: 130 · 2017: 116 · 2016: 122 · 2015: 111 · 2014: 139 · 2013: 145 · 2012: 132
- FWCI
- 11.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cholinesterase and Neurodegenerative Diseases
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cholinergic hypothesis, age-related memory impairment, cholinergic dysfunction, dementia, cholinergic stimulation, cholinergic blockade
- MeSH terms
- Acetylcholine, Adult, Aged, Aging, Alzheimer Disease, Animals, Brain Chemistry, Choline, Choline O-Acetyltransferase, Cognition, Forecasting, Humans, Memory, Memory Disorders, Models, Neurological, Parasympathetic Nervous System, Parasympathomimetics, Phosphatidylcholines, Receptors, Muscarinic, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review